As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.

Date and Time: Tuesday, 17 September 2024 at 09:00 to Thursday, 19 September 2024 at 17:00

Venue details: Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States

Prices:
Drug Developer Pricing – Conference + Workshop Day : USD 4796.00,
Drug Developer Pricing – Conference Only: USD 2999.00,
Academic Pricing – Conference + Workshop Day : USD 4096.00,
Academic Pricing – Conference Only: USD 2599.00,
Solution Provider Pricing – Conference + Workshop Day: USD 5796.00,
Solution Provider Pricing – Conference Only: USD 3699.00